Black tongue secondary to bismuth subsalicylate: case report and review of exogenous causes of macular lingual pigmentation
- PMID: 20027942
Black tongue secondary to bismuth subsalicylate: case report and review of exogenous causes of macular lingual pigmentation
Abstract
Macular pigmentation of the tongue can be acquired following exposure to exogenous agents. Black lingual hyperpigmentation was observed during the full body skin examination of a man with a history of recurrent metastatic malignant melanoma. His tongue spontaneously returned to its normal pink color later that day. Bismuth subsalicylate (Pepto-Bismol) was suspected as the pigment-inducing agent; subsequently, re-challange with the antacid confirmed it to be the cause of his acquired, albeit transient, black tongue. The ingestion of medications, including other antacids, analgesics, antidepressants, antihypertensives and several antimicrobials has been associated with the development of acquired macular lingual pigmentation. In addition, hyperpigmentation of the tongue has been observed following the deposition of amalgam and the injection of local anesthesia or doxorubicin or interferon alpha and ribavirin. Also, inhalation of heroin and methaqualone vapors or tobacco has resulted in lingual hyperpigmentation. All of the patients with acquired macular lingual hyperpigmentation had tongues with a smooth surface without enlargement of the filiform papillae. Many of the individuals with hyperpigmented tongue had either black or dark skin color. The onset of tongue pigmentation varied from less than one day to several years after initial exposure to the associated exogenous agent. The color of the tongue usually returned to normal after the pigment-inducing agent was discontinued.
Similar articles
-
Black tongue.Arch Dermatol. 2001 Jul;137(7):968-9. Arch Dermatol. 2001. PMID: 11453829 No abstract available.
-
Lingual hyperpigmentation associated with minocycline therapy.Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995 Feb;79(2):180-4. doi: 10.1016/s1079-2104(05)80279-3. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995. PMID: 7614181
-
Salicylate toxicity from chronic bismuth subsalicylate use.BMJ Case Rep. 2020 Nov 30;13(11):e236929. doi: 10.1136/bcr-2020-236929. BMJ Case Rep. 2020. PMID: 33257373 Free PMC article.
-
Pharmacology of bismuth-containing compounds.Rev Infect Dis. 1991 Jul-Aug;13 Suppl 8:S691-5. doi: 10.1093/clinids/13.supplement_8.s691. Rev Infect Dis. 1991. PMID: 1925310 Review.
-
Bismuth subsalicylate: history, chemistry, and safety.Rev Infect Dis. 1990 Jan-Feb;12 Suppl 1:S3-8. doi: 10.1093/clinids/12.supplement_1.s3. Rev Infect Dis. 1990. PMID: 2406853 Review.
Cited by
-
Acute Esophageal Necrosis: A Case of Black Esophagus Associated with Bismuth Subsalicylate Ingestion.ACG Case Rep J. 2014 Apr 4;1(3):131-3. doi: 10.14309/crj.2014.27. eCollection 2014 Apr. ACG Case Rep J. 2014. PMID: 26157851 Free PMC article.
-
Drug-Induced Pigmentation: A Review.Drugs. 2024 Sep;84(9):1071-1091. doi: 10.1007/s40265-024-02062-z. Epub 2024 Aug 1. Drugs. 2024. PMID: 39085684 Review.
-
Bismuth release from endodontic materials: in vivo analysis using Wistar rats.Sci Rep. 2023 Jun 15;13(1):9738. doi: 10.1038/s41598-023-36690-4. Sci Rep. 2023. PMID: 37322106 Free PMC article.
-
Bismuth salicylate for diarrhea in children.Can Fam Physician. 2013 Aug;59(8):843-4. Can Fam Physician. 2013. PMID: 23946025 Free PMC article.
-
Diagnostic value of tongue manifestations for primary Sjögren's syndrome: construction and validation of disease screening model.Front Med (Lausanne). 2025 May 27;12:1552781. doi: 10.3389/fmed.2025.1552781. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40495973 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical